Arun Samidurai
Overview
Explore the profile of Arun Samidurai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
521
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campolo F, Samidurai A
Front Endocrinol (Lausanne)
. 2025 Feb;
16:1548972.
PMID: 39944203
No abstract available.
2.
Chen Q, Li L, Samidurai A, Thompson J, Hu Y, Willard B, et al.
FASEB J
. 2024 Jan;
38(2):e23404.
PMID: 38197290
The induction of acute endoplasmic reticulum (ER) stress damages the electron transport chain (ETC) in cardiac mitochondria. Activation of mitochondria-localized calpain 1 (CPN1) and calpain 2 (CPN2) impairs the ETC...
3.
Samidurai A, Olex A, Ockaili R, Kraskauskas D, Roh S, Kukreja R, et al.
Cells
. 2023 Dec;
12(24).
PMID: 38132140
The inhibition of mammalian target of rapamycin (mTOR) with rapamycin (RAPA) provides protection against myocardial ischemia/reperfusion (I/R) injury in diabetes. Since interactions between transcripts, including long non-coding RNA (lncRNA), microRNA(miRNA)...
4.
Samidurai A, Kukreja R
Cardiovasc Drugs Ther
. 2023 Dec;
38(3):411-413.
PMID: 38055185
No abstract available.
5.
Samidurai A, Saravanan M, Ockaili R, Kraskauskas D, Lau S, Kodali V, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37240345
Robust activation of mTOR (mammalian target of rapamycin) signaling in diabetes exacerbates myocardial injury following lethal ischemia due to accelerated cardiomyocyte death with cardiac remodeling and inflammatory responses. We examined...
6.
Samidurai A, Xi L, Das A, Kukreja R
Annu Rev Pharmacol Toxicol
. 2022 Oct;
63:585-615.
PMID: 36206989
Cyclic guanosine monophosphate (cGMP), an important intracellular second messenger, mediates cellular functional responses in all vital organs. Phosphodiesterase 5 (PDE5) is one of the 11 members of the cyclic nucleotide...
7.
Kukreja R, Wang R, Koka S, Das A, Samidurai A, Xi L
Mol Cell Biochem
. 2022 Aug;
478(3):679-696.
PMID: 36036333
Type 2 diabetes (T2D) is one of the major risk factors for developing cardiovascular disease and the resultant devastating morbidity and mortality. The key features of T2D are hyperglycemia, hyperlipidemia,...
8.
Samidurai A, Ockaili R, Cain C, Roh S, Filippone S, Kraskauskas D, et al.
STAR Protoc
. 2021 Sep;
2(3):100772.
PMID: 34485939
We developed a preclinical model of myocardial ischemia/reperfusion (I/R) injury in conscious diabetic rabbits to identify an early pharmacological intervention for patients with diabetes and acute myocardial infarction (AMI). Here,...
9.
Samidurai A, Xi L, Das A, Iness A, Vigneshwar N, Li P, et al.
Pharmacol Ther
. 2021 Apr;
226:107858.
PMID: 33895190
Cyclic nucleotide phosphodiesterases (PDEs) are superfamily of enzymes that regulate the spatial and temporal relationship of second messenger signaling in the cellular system. Among the 11 different families of PDEs,...
10.
Yuan X, Bhat O, Samidurai A, Das A, Zhang Y, Li P
Front Cell Dev Biol
. 2021 Jan;
8:597423.
PMID: 33409276
Recent studies reported that vascular endothelial cells (ECs) secrete NLR family pyrin domain-containing 3 (NLRP3) inflammasome products such as interleukin-1β (IL-1β) via extracellular vesicles (EVs) under various pathological conditions. EVs...